We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

"Social Acceptance Among Peers and Musculoskeletal Pain in Adolescents"

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04526522
Recruitment Status : Completed
First Posted : August 26, 2020
Last Update Posted : June 10, 2021
Sponsor:
Information provided by (Responsible Party):
Britt Elin Øiestad, Oslo Metropolitan University

Brief Summary:
Musculoskeletal pain is common and often occurs already in adolescence. To be able to target future interventions that aim to prevent new episodes of MSK pain, more studies on modifiable risk factors are necessary. In this prospective cohort study, already collected data from the Fit Futures study will be used. The aim is to investigate if perceived social acceptance among peers in the first year of high school is associated with musculoskeletal pain in the last year of high school, and if this association is moderated by psychological distress.

Condition or disease Intervention/treatment
Musculoskeletal Pain Other: No intervention

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 961 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Does Low Social Acceptance Among Peers Increase the Risk of Future Persistent Musculoskeletal Pain in Adolescents? Prospective Data From the Fit Futures Study
Actual Study Start Date : September 1, 2010
Actual Primary Completion Date : June 1, 2013
Actual Study Completion Date : September 2013

Intervention Details:
  • Other: No intervention
    No intervention


Primary Outcome Measures :
  1. Weekly musculoskeletal pain lasting for at least 3 months or more [ Time Frame: 2 years ]
    Persistent or recurrent musculoskeletal pain lasting for at least 3 months or more. The questionnaire included question about pain duration in 14 body regions. Shoulder, arm/elbow, hand, hips, thigh/knee/shin, ankle, neck, upper back, lower back were used to define MSK pain based on the body regions from the Nordic Musculoskeletal Pain Questionnaire. The responses were yes or no, and duration ranged from everyday to rarer than every week.


Secondary Outcome Measures :
  1. Severe weekly MSK pain lasting for at least 3 months or more [ Time Frame: 2 years ]
    Persistent or recurrent MSK pain lasting for at least 3 months or more with a severity of at least 5 on a scale from 0-10 (0= no pain, 10=Worst pain imaginable). The questionnaire included question about pain duration in 14 body regions. Shoulder, arm/elbow, hand, hips, thigh/knee/shin, ankle, neck, upper back, lower back were used to define MSK pain based on the body regions from the Nordic Musculoskeletal Pain Questionnaire. The responses were yes or no, and duration ranged from everyday to rarer than every week.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Norwegian adolescents of 15-18 years of age.
Criteria

Inclusion criteria:

  • Adolescents between 15 and 16 years who live in Tromsø or Balsfjord Municipality

Exclusion criteria (main analysis):

  • Persistent MSK pain at baseline

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04526522


Locations
Layout table for location information
Norway
Oslo Metropolitan University
Oslo, Norway
Sponsors and Collaborators
Oslo Metropolitan University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Britt Elin Øiestad, Associated Professor, Oslo Metropolitan University
ClinicalTrials.gov Identifier: NCT04526522    
Other Study ID Numbers: 2019/599
First Posted: August 26, 2020    Key Record Dates
Last Update Posted: June 10, 2021
Last Verified: June 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Britt Elin Øiestad, Oslo Metropolitan University:
musculoskeletal pain
adolescent
risk factor
Additional relevant MeSH terms:
Layout table for MeSH terms
Musculoskeletal Pain
Muscular Diseases
Musculoskeletal Diseases
Pain
Neurologic Manifestations